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ABSTRACT 
Although multisite toxicity of bilirubin towards metabolism of cells is weO 
known (Karp, 1979), mechanism of bilirubin entry from plasma to ceUs is still 
an enigma. Several studies have been performed to unravel the pathway (s) 
through which biliaibin enters into the cells using red blood cells as a model. 
But there is no clear evidence about the nature of membrane receptors for 
bilirubin. However, participation of membrane proteins as receptors has been 
excluded in an earlier study, but it is suggested that membrane proteins may 
function as an effective barrier to the binding of bilirubin (Sato & Kashiwamata, 
1983). Further, it is proposed that negatively charged phosphate groups of 
phospholipids on the membrane surface may prevent a large amount of 
bilirubin from binding to the membrane (Sato etaJ. 1987). Since the membrane 
make-up of erythrocytes varies from species to species (Lenard, 1970; 
Barenholz & Thompson, 1980), we have studied the binding of bilirubin to 
erythrocytes from four different species namely, human, goat, buffalo and 
sheep both in the presence as well as in the absence of their respective plasma 
albumins under identical conditions of pH (8.0), temperature (37°C) and ionic 
strength (0.414). 
When the bilirubin concentration was kept constant and albumin 
concentration varied to give different bilirubin/albumin molar ratios in the 
range of 0.5 to 3.0, the amount of erythrocyte-bound bilirubin increased with 
the increase in bilirubin/albumin molar ratio. The increase was four fold at 
(I) 
bilirubin/albumin molar ratio of 2.0. The pattern of bilirubin binding to 
erythrocytes at increasing bilirubin/albumin molar ratios was found to be similar 
under both the conditions; i.e. at constant bilirubin and increasing albumin 
concentrations or at constant albumin and increasing bilirubin concentrations. 
However, at any given bilirubin/albumin molar ratio above 1:1 under both the 
above conditions, goat erythrocytes bound the highest amount of bilirubin 
followed by buffalo and human erythrocytes, whereas sheep erythrocytes 
bound the lowest amount of bilirubin. Further, at a ^ven constant bilirubin/ 
albumin molar ratio, the binding of bilirubin to erythrocytes increased lineariy 
with increase in bilirubin concentration. However, the value of the slope of the 
linear plots at any given bilirubin/albumin molar ratio was found to be different 
for different erythrocytes being highest for goat erythrocytes followed by buffalo 
and human erythrocytes and lowest for sheep erythrocytes. When slopes were 
plotted against bilirubin/albumin molar ratio, there was an initial rapid increase 
in the slope and then it became somewhat constant at higher molar ratios, 
suggesting the saturation of bilirubin binding sites in the erythrocyte 
membranes. 
The ipercentage difference in fractional binding of bilirubin to erythrocytes 
as calculated from the above data was found highest in between bilimbin/ 
albumin molar ratios of 1.5 and 2.0. However, at other molar ratios, its value 
was nearly equal. A comparison of the percentage difference in fractional 
bilirubin binding at molar ratios 1.5 to 2.0 shows that goat erythrocytes have 
the highest percentage followed by buffalo and human erythrocytes and sheep 
(ii) 
erythrocytes have the lowest value. Further, calculation of the relative 
percentage difference in the bilirubin bound to erythrocytes of sheep, buffalo 
and goat with respect to the bilirubin bound to human erythrocytes shows that 
goat and buffalo erythrocytes bind bilirubin 31.8% and 11.4% respectively 
more whereas sheep erythrocytes bind 8.7% less bilirubin. These differences 
in erythrocyte-bound bilirubin can not be attributed to the albumin effect as 
the elution of erythrocyte-bound bilirubin with human, goat, buffalo and sheep 
plasma albumins yielded the same amount of bilirubin from human 
erythrocytes. Further, in all the mammalian species studied, the binding of 
bilirubin to erythrocytes was found to be more or less completely protected in 
the presence of their respective albumins at a bilirubin/cilbumin molar ratio of 
0.5. All these results, in combine, suggest that difference in bilirubin binding to 
various mammalian erythrocytes might be due to the difference in the number 
as well as the affinities of the receptors present on these membranes. 
In the absence of albumin, curves between erythrocyte-bound bilirubin 
and bilirubin in the incubate followed Michaelian saturation kinetics. The 
dissociation constant of the bilirubin-receptor complex and saturation were 
calculated using double reciprocal plots. Among the various erythrocytes, goat 
erythrocytes had the highest dissociation constant (265.7 /xmol/1) and highest 
saturation (125.9 /xM) whereas sheep erythrocytes had the lowest dissociation 
constant (115.6 /xmol/1) and lowest saturation (62.5 fiM). Buffalo and human 
erythrocytes bound bilirubin in a similar fashion and the values of interaction 
parameters were in between the values obtained with those of goat and sheep 
(ili) 
erythrocytes. Thus, it appears that the number of saturable bilirubin binding 
sites on goat erythrocytes is highest of all the species studied whereas the 
number of sites on sheep erythrocytes is the lowest. Human and buffalo 
erythrocytes have neariy the same number of binding sites and the values were 
in between the values obtained with goat and sheep erythrocytes. In contrast, 
the affinity of these sites is highest in sheep erythrocytes and lowest in goat 
erythrocytes. Human and buffalo erythrocytes have similar affinities falling in 
between the affinities or sheep and goat erythrocytes. 
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INTRODUCTION 
Under physiological conditions, in human adult, 1-2 x 10^ erythrocytes 
are destroyed per hour resulting in a turn over of approximately 6 gm of 
haemoglobin per day by a 70 kg human (Schmid & McDonough, 1978). Both 
the protein, globin and iron of haemoglogin are reutilized by the body, but the 
iron-free porphyrin portion of haeme is catabolized mainly in the 
reticuloendothelial cells of the liver, spleen, and bone marrow producing a 
yellow pigment called bilimbin IX-a Bilirubin IX-a can be isolated from gall 
stones and is the most commonly found natural linear tetrapyrrole. It is 
estimated that 1 gm of haemoglobin yields 35 mg of bilirubin. Thus, about 
250-350 mg of bilirubin is produced per day in human adults. 
Properties of bilirubin 
(i) Chemical properties : Bilirubin is described as a polar structure 
with several groups capable of forming hydrogen bonds, namely, two carboxyls, 
two pyrrol -NH, two lactam-NH and two lactam carbonyls and several 
hydrophobic groups i.e. four methyls, two vinyls, two ethylenes, and one 
methylene (see Fig.l a & b). The protoporphyrin IX, the parent molecule, 
which occurs in Z- configuration mainly opens at the a- methin bridge during 
catabolism, leading to the fonnation of bilirubin IX-a (Z,Z). This is present 
either as dianion or inbramolecularly hydrogerv bonded bilirubin acid as shown 
in Fig. 1 b. However, little amounts of protoporphyrin IX also undergo 
cleavage at the 6, y or 5 positions yielding about 5% of bilirubin non-a isomers 
2 
(i) 
COOH COOH 
(ii) 
COOH COOH 
HOOC 
Figure 1. (a)Chemiccd structure of bilirubin. 
(i) Protoporphyrin IX. (ii) BUirubin IX-a. (iii) Bilirubin IX-a 
(acid), (iv) Bilirubin IX-a (dianion). 
COOH 
HOOC 
'OCC 
*occ 
-CM-
COO' 
"00c CC<0° 
Figure 1. (b) Photoisomers and isomers of bilirubin. 
(i) The mother compound, bilirubin IX-a (Z,Z) is transformed into 
(E,Z) or possibly (E,E), also called photobilirubins. (ii) Bilirubin 
IX-a (acid), intramoleculariy hydrogen bonded (iii) Bilirubin IX-6. 
(iv) Bilirubin IX-y. and (v) Bilirubin IX-8 
such as bilimbin IX-13, IX-y or IX-5 (Brown, 1976; Blanckaert et aJ., 1975, 
1976; Blumenthal etal., 1977; Heirwegh etal., 1977). Upon illumination with 
blue light, bilirubin IX-a (Z,Z) undergoes cis-trans isomerization producing 
bilirubin IX-a {E,Z) or possibly bilirubin IX-a (E,E) called photobilirubins 
(Lightner & Park, 1977, Pedersen et al., 1977) which can no longer form the 
pattern of intramolecular hydrogen bonds. 
(ii) Solubility: Bilirubin IX-a (Z,Z) is nearly insoluble in water at 
pH values below 7 while non-a isomers and the photobilirubins (E,Z and E,E) 
are more soluble (Overbeek eta/., 1955; Brodersen, 1979). Only a- isomers 
in (Z,Z) configuration, with undissociated carboxyl groups are capable of 
forming a complete pattern of intramolecular hydrogen bonds, saturating all 
affinities for water and are insoluble. In non-a isomers, the carboxyl groups are 
located differently, relative to the lactam groups and pyrrol nitrogen atoms and 
this is also the case in photoisomers where the outer rings have been turned, 
fonning E-configurations. All these have one or several hydrophilic moieties 
available for binding of water molecules and thus are water soluble even in 
acid solution. The solubility of bilirubin acid being too low in water, has been 
measured in several solvents (Brodersen, 1979). The solubility of bilirubin in 
apolar solvents, such as rvhexane is less than 1 /xM and generally increases 
with increasing solvent polarity, reaching to a value higher than 10 mM in 
dimethyl sulphoxide (Brodersen, 1979). 
Several authors have stated that bOirubin is a lipophilic substance. This 
is mainly due to the work of Mustafa and King (1970) who demonstrated the 
5 
binding of bilirubin to lipid-water interpFiases containing lipids of a polar nature. 
Another consideration of bilirubin lipophillcity is the insolubility of bilirubin acid 
in water due to intramolecular hydrogen bonding (Bonnett etaJ., 1976), wherby 
all hydrophilic groups in the molecule are saturated. This molecule is also 
insoluble in carbon hydrides and alcohols and has a low solubility in carbon 
tetrachloride, diethyl ether, acetone, ethsd acetate and triglycerides, while its 
solubility is high in formamide and dimethyl sulphoxide. A substance with 
these solubility characteristics can hardly be considered as lipophilic (Brodersen, 
1979). 
(iii) Spectroscopic properties : Light absorption spectrum of 
bilirubin IX-a (Z,Z) acid, dissolved in organic solvents shows two maxima, one 
weak band at about 290 nm and another intense maximum at 450 to 460 nm 
(Heilmeyer, 1931), while spectrum of norva isomers of bilirubin in dimethyl-
formamide solution shows similar maximum although the main peak is located 
at shorter wavelength 390 to 410 nm (Blanckaert et a/., 1976). Bilimbin IX-
a (Z,Z) add dissolved in chloroform has light absorption maximum at 454 nm 
and a specific extinction coefficient close to 1.04 x 10^ (Jacobsen & Brodersen, 
1983). 
Dilute solutions of bilirubin disodium salt in alkaline aqueous media 
have light absorption maximum around 430 to 440 nm, depending upon 
buffer composition and temperature (Carey & Koretsky, 1979). A molar 
absorption coefficient of 4.7 to 5.2 x 10* M"^  cm'^  has been reported by several 
investigators (Carey & Koretsky, 1979; McDonagh, 1979; Blauer eta/., 1972). 
6 
The spectrum is constant with pH varying from 8 to 12. At low concentrations 
of bilirubin, from about 20 nM, which is the practical lower limit for 
spectroscopic recording, to an upper limit between 1.0 to 10 /xM, the spectrum 
remains constant when normalized to one concentration. But if the alkaline 
bilirubin solution is fairly concentrated (0.1 mM or more) and is neutralized to 
pH 7.0, colloid aggregation of the acid can be observed by an immediate rise 
of light scattering to high values, indicating formation of large particles. The 
light absorption spectrum shows a slight, immediate loss of intensity followed 
by marked decrease of the peak at 440 nm and an increase of absorption at 
500 nm with increasing time. 
Bilirubin catabolism in vivo 
In plasma, bilirubin is protein bound, specifically to albumin. This 
albumin-bound bilirubin is known as conjugated while unbound one as 
unconjugated. Small amount of bilirubin is also conjugated with glucose 
(Blanckaert et al., 1974) and xylose (Compemolle et ai, 1971; Fevery et al., 
1977). In the liver, albumin-bound bilirubin is removed firom the albumin and 
taken up at the sinusoidal surface of the hepatocytes by a carrier-mediated 
saturable system. The smooth endoplasmic reticulum provides a specific set of 
enzymes which convert bilirubin into diglucuronide. This conversion can also 
take place in the kidney and the intestinal mucosa. Secretion of this conjugated 
bilirubin into the bile occurs against a large concentration gradient and is 
canied out by an active transport mechanism. As the conjugated bilirubin 
reaches the terminal ileum and the large intestine, the glucuronides are 
removed by specific bacterial enzymes and the pigment is subsequently 
reduced by the fecal flora to a group of colourless tetrapyrrolic compounds, 
called urobilinogens fomned in the colon, oxidized to urobilins and finally 
excreted in the feces (Schmid & McDonough, 1978). 
Bilirubin binding to serum albumin 
Serum albumin, a nonglycoprotein is known to bind a variety of 
substances both cationic and anionic differing in structure and chemical 
properties (Peters, 1970; 1975; 1980; 1985) and large number of drugs 
(Brodersen, 1974; Brodersen etal., 1977; Robertson etal., 1991; Onks et al., 
1991; Evans etal., 1992). Among the anionic ligands known to bind albumin, 
long chain fatty acids (Brown & Shockley, 1982), bilimbin (Brodersen, 1979; 
Tayyab & Qasim, 1988) and tryptophan (Fehske et al., 1979) are 
physiologically important. 
Binding of bilirubin to serum albumin was first reported in 1949 (Martin, 
1949). Earlier, it was suggested that one albumin molecule could bind two to 
three molecules of bilirubin (Martin, 1949; Odell, 1959; Watson, 1962; Schmid 
et al., 1965). However, others (Ostrow & Schmid, 1963; Kaufmann et al., 
1969; Kucerova & Jirsa, 1969; Brodersen, 1979; Jacobsen & Brodersen, 
1983) have described that albumin probably has two binding sites for bilirubin, 
one of which has a much higher affinity than the other. Jacobsen in 1969, 
using the peroxidase method, prepared the first binding isotherm for bilirubin-
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albumin and showed that one molecule of bilirubin is bound with high affinity 
(Ka= 1.4 X10^ litreVmole) and that the isothemi further con-esponds to binding 
of two additional molecules of the pigment with lower affinity (Ka= 5 x 10^ 
litres/mole) (Jacobsen, 1969). The binding affinity of bilirubin to the high 
affinity binding site of albumin is well worked out. Different methods used for 
the determination of binding constants of the high as well as low affinity 
binding sites give fairly constant results (see Table I). However, the binding of 
third molecule of bilirubin has not been demonstrated by most of the 
techniques. 
If has been shown that albumin binds bilirubin reversibly in plasma and 
even at bilirubin/albumin molar ratio of 1:1, a very small fraction of the total 
bilirubin remains as unbound fraction (Brodersen, 1979; Wennberg et al., 
1979; Wennberg, 1988). The binding affinity of bilirubin to serum albumin has 
been reported to be independent of pH firom 7.0 to 9.0 (Wennberg, 1971; 
Nelson et al., 1974; Jacobsen & Brodersen, 1976; Wennberg & Rasmussen, 
1978; Brodersen, 1979) However, albumin does not bind bilirubin above pH 
12.0 because of unfolding of albumin and due to the insolubility of bilirubin 
at low pH, it is not possible to investigate whether it can be bound to serum 
albumin or not (Brodersen, 1979). Fiirther, the affinity of bilirubin binding to 
albumin for primary binding site has been found to decrease with increasing 
temperature and ionic stirength (Jacobsen, 1977). This suggests the role of 
eledrostatic interactions in the binding process. 
11 
Bilirubin toxicity and bilimbin encephalopathy 
Hervieux in 1847 first described yellow staining of the basal ganglia in 
association with neonatal jaundice (Herweux, 1847) and the phenomenon 
was temied as l<emicterus by Schmori in 1904 (Schmorl, 1904). This tenn has 
since been used to describe both the acute, often fatal condition in the newborn 
with substantial elevation of serum bilirubin levels, seizures, opisthotonus, and 
bleeding tendency, as well as the neurologic sequelae in survivors, consisting 
of choreoathetosis, asymmetric spasticity, paresis of upward gaze and 
neurogenic hearing loss (Byers et aJ., 1955; Peristein, 1960; Hyman et aJ., 
1969; Keaster et al., 1969; Fenwick, 1975). But now-a-days, the tenn 
kemicterus is replaced by another term bilirubin encephalopathy, so as to 
include all conditions in which bilirubin is known or thought to be the cause 
of brain toxicity (Hansen & Bratlid, 1986). Several studies have shown that 
bilirubin influences several enzymic system (Karp, 1979). It inhibits the binding 
of cAMP to protein kinase (Constantopoulos & Matsaniotis, 1976). However, 
rat liver ATP-ase has been reported to be stimulated by bilimbin (Zetterstrom 
& Emster, 1956). Glycogenesis is stimulated in the brain of congenitally 
hyperbilirubincmic rats (Gunn rats) (Karp, 1979). It causes complete inhibition 
of DNA synthesis in Morris hepatoma cells at concentrations of 170 L^tM after 
10 minutes of exposure (Thaler, 1971). In cultured human fibroblasts, bilirubin 
combined with phototherapy induced strand breakage in DNA (Rosenstein et 
al., 1983; Rosenstein & Ducore, 1984). 
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Nature of bilirubin involved in bilirubin cell toxicity is still a controversy. 
It has been suggested that kemicterus and bilirubin toxicity are caused by the 
bilirubin-albumin complex crossing a disrupted blood-brain barrier and that the 
level of free bilirubin or nature of bilirubin binding may not be important in 
the development of bilirubin encephalopathy (Levine et al., 1982) . On the 
other hand, studies on the effects of bilirubin on respiration and viability in cell 
cultures have shown that toxicity increases when bilirubin is present in the 
incubate in molar concentrations which exceed that of albumin (Lie & Bratiid, 
1970; Bratiid & Rugstad, 1972). Further, if albumin is present in an equimolar 
or higher ratio with bilirubin, toxicity is blocked (Rasmussen & Wennberg, 
1972). Now, it is well recognized that free unconjugated bilirubin is the potential 
cytotoxic substance and its damaging effect on the cells of the central nervous 
system in newborns, suffering from a severe form of hyperbilirubinemia 
(kemicterus) is well known (Metze, 1977; Odell, 1980). Even other cell types 
and tissues, e.g., platelets, heart, kidney, Langerhans islets of the pancreas, 
liver and teeth are reported to be damaged by free unconjugated bilirubin 
(Metze, 1977). Unconjugated bilirubin also induces platelet aggregation (Moiny 
etal., 1990) and posseses a direct cytotoxic effect for human lymphocytes and 
granulocytes (Milcr et al., 1985). During the in vito interaction between 
bilirubin and cells, bilirubin undergoes degradation due to both adsorption to 
the cells and action of cell enzymes (Knobloch & Miler, 1987). 
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Binding of bilirubin to erythrocytes 
Binding of biiimbin to erythrocytes was first reported by Watson (1962) 
wiio also demonstrated that presence of certain drugs such as sulphonamide 
and sodium salicylate greatly enhanced this binding. Later on, several other 
workers have also studied the binding of bilirubin to erythrocytes and 
erythrocyte ghosts in greater detail (Oski & Naiman, 1967; Cheung et aJ., 
1966; Kaufmann et al., 1967; Bratlid, 1972 a & b; Bamhart & Clarenburg, 
1973; Kapool, 1975; Thaler & Wennberg, 1977; Bouillerot et al., 1981; Sato 
& Kashiwamata, 1983; Sato et al., 1987; Gulian, 1987; Hayer et aJ., 1989). 
The amount of erythrocyte-bound bilirubin is increased either on increasing 
the bilirubin concentration, while keeping the bilirubin/albumin molar ratio 
constant or by increasing the bilirubin/albumin molar ratio while keeping the 
bilirubin concentration constant (Bratlid, 1972 a). At any constant bilirubin/ 
albumin molar ratio below 1:1, increase in bilirubin concentration leads to a 
smaller increase in erythrocyte-bound bilirubin. On the other hand, erythrocyte-
bound bilirubin is increased around four fold on increasing bilirubin 
concentration at any bilirubin/albumin molar ratio above 1:1 (Kaufmann etal., 
1967; Bratlid, 1972 a; Bamhart & Clarenburg, 1973). BUimbin binding to 
erythrocytes takes place within 10 minutes and further increase in the 
incubation time does not result in any increase in erythrocyte-bound bilirubin 
(Bamhart & Clarenburg, 1973; Sato & Kashiwamata, 1983). At a given 
albumin concentration, erythrocytes and albumin bind constant proportions of 
bilirubin, despite varying bilirubin concentrations (Bamhart & Clarenburg, 
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1973). However, Wennberg & Rasmussen (1978) have reported that at 
equilibrium, the cellular content of bilirubin is a function of the concentration 
of free bilirubin acid and not the total bilirubin concentration or bilirubin/ 
albumin molar ratio. 
Effect of pH on the binding of bilimbin to erythrocytes, erythrocyte ghost 
and other cell types has been studied earlier by several workers and an increase 
in erythrocyte-bound bilirubin has been reported with decreasing pH ( Bratiid, 
1972 b; Nelson et aJ., 1974; Sato & Kashiwamata, 1983; Wennberg, 1988). 
In presence of albumin, decrease in pH from 7.4 to 6.S results in an increase 
in erythrocyte-bound bilimbin at all the bilirubin/albumin molar ratios, including 
molar ratios below 1:1 (Bratiid, 1972 b). However, Sato & Kashiwamata 
(1983) have reported that the saturable binding of bilirubin to the erythrocyte 
membranes has a pH optimum around 7.1. They have suggested that the 
cellular susceptibility io bilirubin at lower pH may be determined not only by 
the physical state of bilirubin but also by the physico-chemical conditions of 
bilirubin binding sites on the membranes. This has been supported by an 
earlier finding (Bratiid, 1972 b) that in absence of albumin, at higher bilirubin 
concentrations, there is an increase in erythrocyte-bound bilirubin on decreaang 
pH, although at lower bilirubin concentrations, decrease in pH does not affect 
the en/throcyte-bound bilirubin. Thus, it appears that bilirubin binding to 
erythrocytes not only depends upon pH but also on bilirubin concentration. 
Most of the workers (Odell, 1970; Zamet & Chunga, 1971; Bratiid, 1972 b; 
Maisels, 1972) are of the view that increased cellular binding of bilirubin at 
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lower pH may be due to either increased cellular affinity for bilirubin or 
increased dissociation of bilirubin from the secondary binding sites of albumin 
at low pH without any reduction in the affinity of the primary binding site. 
The molecular basis of bilirubin binding mechanism to erythrocytes is 
still not clear. But, there are some clues which are important for elucidation of 
this mechanism. It is reported that bilirubin is not solely bound to the 
membranes but that its greater part is also present in the cytosol of erythrocytes 
(Lamola et al., 1979). This is also supported by the finding that stroma binds 
less bilirubin as compared to the whole cells, which means that some of the 
bilirubin might bound to other structures other than the stroma (Bratlid, 1972 
a). Albumin-bound bilirubin could not penetrate into the cell membranes 
whereas unconjugated bilirubin can diffuse freely through biological 
membranes as it has been found accumulated in the intracellular compartments 
such as mitochondria (Odell, 1965, 1966; 1970; Wennberg, 1988). The same 
amount of bound bilirubin is reported in both red blood cells and erythrocyte 
ghosts having same phospholipid content (Hayer et al. 1989). Thus, it appears 
that unlike other cells, erythrocytes have all the bilirubin as membrane-bound. 
Bilirubin binds to the specific binding sites present in the membrane. They 
have reported the binding saturation of 110 x 10-^ ^ moles of bilirubin per red 
blood cell and the dissociation constant of bilirubin/receptor complex as 170 
X 10^ mol/1 (Hayer et al., 1989). Sato & Kashiwamata (1983) have reported 
the apparent dissociation constant (Kd) and maximum binding (B^^) values 
for the saturable binding of bilirubin as 2.3 /itM and 0.93 nmol/mg of membrane 
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protein respectively. Individual membrane components responsible for the 
binding of bilirubin have not been characterised yet. However, no difference 
has been found in between erythrocytes from patients with glucose-6-
phosphate dehydrogenase deficiency and erythrocytes from normal 
hyperbilirubinemic infants, with respect to bilirubin binding (Schettini & Meloni, 
1964). Similarly, no difference has been reported in bilirubin binding capacity 
of erythrocytes from newborn infants with erythroblastosis from that of normal 
erythrocytes at bilirubin/albumin molar ratios below 1:1. But above molar 
ratios 1:1, the patient erythrocytes bind little less bilirubin (Bratlid, 1972 a). 
The bilirubin binding sites in erythrocyte membranes appear not to be 
composed of proteins as the binding capacity increased after tryptic digestion 
and heat treatment of these membranes (Sato & Kashiwamata, 1983). Further, 
affinity labelling of the membrane proteins by bilirubin has not been successful 
in identifying any specific bilirubin binding protein (Sato & Kashiwamata, 
1983). They have suggested that membrane proteins may function as an 
effective barrier to the binding of bilirubin. Nagaoka & Cowger (1978) have 
suggested that bilirubin is bound to the lipid bilayers through sti-ong ionic 
interactions between a cationic head group of the lipid cind anionic bilirubin. 
Binding constant has been reported highest for sphingomyelin as 3.7 xlO^M*, 
and for dlphosphatidylcholine with 5% cholesti'ol as 2.6 x 10^ M ^ Bilirubin-
phosphatidylcholine complex fomiation as reported by Mustafa & King (1970), 
is also reported to be fonned in diethyl ether solution (Brodersen, 1979). Sato 
etaJ. (1987) have reported that neuraminidase and phospholipase D digestions 
17 
do not effect the binding capacities, but phospholipase C treatment greatly 
eniiances the bilirubin binding. Further, inside-out sealed erythrocyte vesicles 
show compjarable binding capacities with the right-side-out sealed membranes. 
On the basis of their results, these authors have rejected the idea of the 
involvement of polar headgroups of phospholipids as the binding sites for 
bilirubin on the plasma membranes as suggested by Mustafa & King (1970) 
and Nagaoka & Cowger (1978). They have suggested that the negatively 
charged phosphoric acid moiety of phospholipids prevents a large amount of 
bilirubin from binding to the membranes and that the bilirubin binding sites 
might be distributed on both outer and inner surface of the membranes, or 
might exist in the membranes where bilirubin might be accessible from either 
side. 
From the above review of the literature, it is clear that erythrocytes have 
saturable binding sites for bilirubin. Despite extensive studies, the nature of 
these receptors has not been defined. Further, there is no report on whether 
erythrocytes from different mammalian species bind same amount of bilirubin 
or not. Since there is a difference in protein and lipid make-up of erythrocyte 
membranes of different mammalian species (Lenard, 1970; Barenholz & 
Thompson, 1980), it would be interesting to carry out detailed studies on the 
binding of bilirubin to erythrocytes of different mammalian species. This will be 
helpful in characterizing the receptors for bilirubin present on these cells. With 
this idea in mind, I decided to undertake a detailed study on the binding of 
bilirubin to erythrocytes from different mammalian species, namely, human, 
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buffalo, goat and sheep both in the absence and in the presence of their semm 
albumins respectively. This dissertation describes a report on the comparative 
studies on bilirubin binding to erythrocytes from different mammalian species 
under four different conditions i.e. (i) at different bilirubirValbumin molar ratio 
(keeping bilirubin concentration constant while varying the albumin 
concentration) (ii) at different biiirubin/albumin molar ratios (keeping albumin 
concentration constant while varying bilirubin concentration) (iii) at increasing 
bilirubin concentrations (keeping bilirubin/ albumin molar ratio constant while 
varying both bilirubin and albumin concentrations and (iv) in absence of 
albumin. 
The results of this study suggest that goat erythrocytes bind highest 
amount of bilirubin followed by buffalo and human while sheep erythrocytes 
bind lowest amount of bilirubin. 
Future plan of work 
Although, the amount of bilirubin bound to erythrocytes from different 
mammalian species is different as shown in this study , but the molecular 
organization of binding sites in erythrocyte membranes, such as the 
involvement of proteins, lipids, carbohydrates as well as the effect of erythrocyte 
volume and intracellular Ca-^ ^ content, are poorly understood. Therefore, in 
future, I would like to study in detail the binding of bilimbin to erythrocytes of 
human, goat, buffalo and sheep under the following conditions: 
(i) Bilirubin binding studies with different age groups of red blood 
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cells. 
(ii) Bilirubin binding studies with trypsinized red blood cells, 
phospholipase-treated red cells and sialidase-treated red blood 
cells. 
(iii) Bilirubin binding studies in presence of anion transport inhibitor. 
(iv) Bilirubin binding studies with CaCl2-treated red blood cells. 
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EXPERIMENTAL 
Materials 
Proteins 
Bovine serum albumin fraction V, (Lot No. 100 F - 0249) was purcliased 
from Sigma Chemical Company, USA. Human, buffalo, sheep and goat plasma 
albumins were isolated by the method of Tayyab and Qasim (1990). 
Reagents used in protein determination 
Sodium carbonate, sodium potassium tartarate, lithium sulphate and 
liquid bromine (all GPR grade) were obtained from B.D.H., India. Copper 
sulphate, sodium tungstate and sodium molybdate (all LR grade) were 
purchased from s.d. fine chem., India. Qualigens Fine Chemicals, India was 
the source of orthophosphoric acid and hydrochloric acid. 
Reagents used in bilirubin determination 
Reagents used in bilirubin determination with their sources in parentheses 
were: Caffeine anhydrous (LR), sulphanilic acid (LR), sodium nitrite (AR) (s.d. 
fine chem., India); sodium acetate (AR) (Qualigens Fine Chemicals, India); 
sodium hydroxide (GPR), sodium potassium tartarate (GPR) (B.D.H., India) 
and sodium benzoate (GR) (Loba Chemie, India). 
Reagents used in polyacrylamide gel electrophoresis 
Acetic acid glacial (AR), amido black lOB (LR), glycerol (LR), charcoal 
(GR) and methanol (GR) were purchased from s.d. fine chem., India. 
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Acrylamide (LR), N, N'-methylcnebisacrylamide (LR) and N, N, IvT, N'-
tetramethylethylenediamine (LR) were obtained from S.R.L., India. B.D.H., 
India was the source of ammonium persulphate (GR), tris (hydroxymethyl) 
aminomethane (LR) and glycine (LR). Bromophenol blue was obtained from 
B.D.H. England 
Miscellaneous 
Various chemicals/reagents used in this study with their sources in 
parentheses were : ammonium sulphate (LR), ammonia solution, sodium 
chloride (AR) (Qualigens Fine Chemicals, India); bilirubin (GR), pxDtassium 
dichromate (AR), potassium hydrogen phthalate (LR), sodium azide (LR), 
sodium phosphate (mono and dibasic) (LR) (s.d. fine chem., India) and sodium 
carbonate (LR), tri-sodium citrate (LR), sulphuric acid (LR) (B.D.H., India). 
Dialysis membranes of 1 inch diameter were obtained from Sigma 
Chemical Company, USA and Whatman filter paper No. 1 was purchased 
from Whatman Lab. Div, Kent, England. 
All glass distilled water was used throughout these studies. All the 
experiments were perfomed at 25°C unless otherwise stated. 
AR = Analytical Reagent; GR = Guaranteed Reagent; 
LR = Laboratory Reagent; GPR = General Purpose Reagent. 
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Methods 
pH measurements 
pH measurements were made on a digital pH meter, type DPH-100 
using DPH-100 combined electrode. The pH meter was routinely calibrated 
with 0.05 M potassium hydrogen phthalate buffer, pH 4.0 at 25°C in the acidic 
range and with 0.01 M sodium tetraborate buffer, pH 8.2 at 25°C in the 
alkaline range. 
Optical measurements 
Light absorption measurements were made on either Cecil single beam 
spectrophotometer, model CE-202 or Photochem-8 colorimeter using quartz 
or glass cuvettes of 1 cm path length. 
Determination of protein concentration 
Protein concentration was determined by the method of Lowry et al. 
(1951) using bovine serum albumin as the standard. This method involves the 
use of two reagents, namely, Fblin & Ciocalteu's phenol reagent and copper 
reagent. These reagents were prepared in the following manner. 
(i) Preparation of copper reagent: The following stock solutions were 
prepared. 
(1) 4% (w/v) sodium carbonate 
(2) 4% (w/v) sodium potassium tartarate 
(3) 2% (w/v) copper sulphate. 
23 
In order to prepeure the copper reagent, the solutions (1), (2) and 
(3) were mixed in the ratio of 100 : 1 : 1 (v/v/v). First the solution (2) 
was added to solution (1) and after mixing, solution (3) was added to 
the mixture of (1) and (2). The sequence of mixing the solutions was 
essential to avoid precipitation. The reagent was filtered before use. 
(ii) Preparation ofFotin & Cio€UiUeu's phenol reagent: The reagent 
was prepared by the method of Folin and Ciocalteu (1927). One 
hundred grams of sodium tungstate, 25 gm of sodium molybdate, 50 ml 
of 85%{v/v) orthophosphoric acid, 100 ml of 11.3 N hydrochloric add 
and 700 ml of water were mixed together and the contents were refluxed 
gently in a two litre round bottom flask wrapped with black paper for ten 
hours. After cooling, 150 gm lithium sulphate, 50 ml of water and few 
drops of liquid bromine were added. The mixture was boiled without 
condenser for 30 minutes to remove excess bromine. The solution was 
cooled, filtered and diluted to one litre. The yellow coloured reagent was 
stored in an amber coloured bottle. The stock solution was diluted five 
times with water before use. 
flllj Procedure: An appropriate volume of standard protein solution (4 mg/ 
10 ml) in the range of 0.1 -1.0 ml was taken in a series of test tubes and 
the total volume was made upto 1.0 ml with water or buffer. Then 5.0 
ml of freshly prepared copper reagent was added to all the tubes and 
after thorough mixing, these were left at room temperature for 10 
minutes. Then 1.0 ml of diluted Folin & Ciocalteu's phenol reagent was 
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Figure 2. Standard curve for the determination of protein concentration by 
the method of Lowry et al. (1951). 
25 
added and the contents were mixed well. After 30 minutes, the colour 
intensity was read at 700 nm against a blank prepared in the same way 
except that instead of protein solution, 1.0 ml of water or buffer was 
taken. A graph was plotted between absorbance at 700 nm and amount 
of protein (Fig. 2), which yielded the following straight line equation : 
(O.Dj^ oo^ ^ = 1.9 (amount of protein, mg) + 0.08 
Isolation of plasma albumin 
Plasma albumin was isolated by the method of Tayyab and Qasim 
(1990). Heparinized human blood was obtained from the Blood Bank of 
Jawaharial Nehru Medical College, Aligarh Muslim University, Aligarh and 
citrated blood of goat, buffalo and sheep were collected from the slaughter 
house. Blood was centrifuged at 3000 rpm for 20 minutes to obtain plasma. 
To each 500 ml of plasma in a one litre conical flask was added sufficient 
amount of 4 M ammonium sulphate solution (whose pH had been previously 
adjusted to 7.0 with ammonium hydroxide) to make the plasma 2.26 M in 
ammonium sulphate. Each mixture was kept for 12 hours at room temperature 
and then centifuged at 6000 rpm for 30 minutes. The precipitate was discarded 
and the supernatant thus obtained was carefully diluted with water such that 
the final concenti-ation of ammonium sulphate was reduced to 1.9 M and the 
pH was adjusted to 4.1 with 0.5 N sulphuric acid. After incubation at room 
temperature for about 12 hours, the precipitate was collected by centrifugation 
at 6000 rpm for 30 minutes. It was washed three times with 2.2 M ammonium 
26 
sulphate sulution, pH 4.2 and then dissolved in 0.07 M sodium phosphate 
buffer containing 0.08 sodium chloride, pH 7.4. The protein, thus obtained, 
was extensively dialysed against 6 litres of 0.07 M sodium phosphate buffer 
containing 0.08 M sodium chloride, pH 7.4. The preparation was stored at 4°C 
and concentration was determined by the method of Lowry et al. (1951). 
Polyacrylamide gel electrophoresis 
Fblyacrylamide gel electrophoresis was performed in tris- glycine buffer. 
pH 8.2, ionic strength 0.02 according to the method of Davis (1964). The gel 
tubes (0.5 X 7.5 cm) were washed with detergent chromic acid and finally with 
water. The dried tubes were siliconized with a solution of 5% (v/v) dimethyl 
dichlorosilane in chloroform. Then the tubes were fixed vertically in a stand by 
keeping the lower ends closed with the help of stoppers. A small pore solution 
containing 7% (w/v) acrylamide, 0.18% (w/v) N, N'- methylenebisacrylamide, 
0.03% (v/v) N,N,N',N'-tetramethylethylenediamine (TEMED) and 0.07% (w/v) 
ammonium persulphate was prepared. To each tube, 1.0 ml of the above 
solution was poured. The surface of the small pore solution was carefully 
layered with few drops of water. After 30 minutes of incubation at room 
temperature (sufficient for polymerization), water layer was removed using 
strips of filter paper. The surface was rinsed with small amount of 
electrophoretic buffer. For sample preparation, 200 /igm protein was taken in 
about 0.1 ml of electrophoretic buffer containing one drop of glycerol. Gel 
tubes were fitted in an electrophoresis assembly. About 0.03 ml of the sample 
was applied and the empty space left in the tube was carefully filled with the 
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electrophorctic buffer. Few drops of a 0.01% (w/v) bromophenol blue in 0.1 
N sodium hydroxide (w/v) solution were added in the upper chamber and then 
the buffer was added in a volume such that the gel tubes were completely 
dipped. An anodic current of 2-4 milliampere per tube was passed till the 
bromophenol blue front had migrated to nearly three fourth of the gel length. 
After 2 hours, electrophoresis was terminated and the gels were taken out from 
the gel tubes and stained for one hour with 1% (w/v) amido black solution 
prepared in 7% (w/v) acetic acid. The position of tracking dye was marked by 
inserting a small piece of wire before placing these gels in staining solution. 
Destaining was performed mechanically by shaking the tubes with 7% (v/v) 
acetic acid at 37°C. 
Determination of bilirubin concentration 
Bilirubin concentration was determined according to the method of 
Jendrassik and Grof (1938) as modified by Fbg (1958). The method involves 
the use of three reagents, namely, 1, II and III which were prepared in the 
following manner: 
(i) Preparation of reagent I: Reagent I was prepared by dissolving 20 
gm of caffeine anhydrous, 30 gm of sodium benzoate and 50 gm of 
sodium acetate in 400 ml of water. The mixture was wanned upto 50°C 
vwth continuous stirring until a clear tiransparent solution was obtained. 
(ii) Preparation of reagent II : Reagent II consists of two parts, i.e. 
reagent Ila and lib. 
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(a) Reagent JIa : Reagent Ila was prepared by dissolving 0.5 gm of 
sulphanilic acid in 1.5 mi of concentrated liydrochloric acid 
followed by dilution witl^  100 ml of water. Heating was avoided 
to prevent crystal formation. 
(b) Reagent lib : Reagent lib was prepared by dissolving 500 mg 
of sodium nitiite in 100 ml of water. 
Working solution of reagent II was prepared fresh just 
before the experiment by adding 3 drops of reagent lib in 5 
ml of reagent IIa. 
(Hi) Preparation of reagent HI: It was prepared by dissolving 30 gm of 
sodium hydroxide and 105 gm of sodium potassium tartarate in 300 ml 
of water. 
Preparation of standard solution of bilirubin : It was prepared by 
dissolving few crystals of bilirubin in 1 N NaOH containing 5 mM EDTA and 
diluting it with 0.06 M sodium phosphate buffer, pH 8.0. Bilirubin concenti^tion 
was determined spectrophotometrically using a molar extinction coefficient of 
47,500 at 440 nm (Jacobsen & Wennberg, 1974). 
Procedure : In a series of tubes, inaeasing volumes of stock bilirubin 
solution (116 /xM) ranging from 0.1 to 1.0 ml were added and the final volume 
was made upto 1.0 ml with water. It was followed by the addition of 2.0 ml 
of reagent I and 0.5 ml of reagent II. The contents were mixed well and kept 
at room temperature for 10 minutes. Then, 1.5 ml of reagent III was added 
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Fog's method (1958). 
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in all the tubes and tubes were shaken well. Absorbance of the solution was 
read at 600 nm. The colour was stable for 30 minutes and incubation of the 
solution longer than 30 minutes resulted in the appearance of turbidity in all 
solutions. For each bilirubin concentration, reagent II blank and bilimbin blank 
were prepared in the same way as described above except that water was used 
instead of reagent II and bilirubin in these blanks respectively. Absorbance of 
diazotized bilirubin solution was determined by subtracting the absorbance 
values of reagent II blank and bilirubin blank from the absorbance of bilirubin 
solution. Data were plotted as absorbance at 600 nm versus bilirubin 
concentration, which yielded the following straight line equation (Fig. 3). 
(O.D.)goo^ ^ = 0.0125 X bilirubin cone. {^M) + 0.02 
In order to check the interference of plasma albumin in the determination 
of bilirubin concentration by Fog's method (1958), the bilirubin solution (770 
/xM) was diluted 10 times with isolated plasma albumin in 0.07 M sodium 
phosphate buffer containing 0.08 M sodium chloride, pH 7.4. The diluted 
bilirubin-albumin solution was used instead of stock bilirubin solution and the 
assay was performed in the same way as described above for bilirubin alone. 
The standard curve (Fig. 3), thus obtained, showed no change in the value of 
slope. Therefore, the standard curve of bilirubin can also be used for 
determination of bilirubin concenti^tion in presence of albumin. 
Similarly, use of stock bilirubin solution prepared in 1 N NaOH 
containing 5 mM EDTA and diluting it with 38 mM sodium carbonate solution 
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Figure 4. Effect of increasing concentrations of sodium azide on total 
bilimbin determination by Fog's method (1958). The concentration 
of bilirubin was 127.0 /xM (•), 90.3 ^iM (0), and 56.0 /xM (0). 
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containing 5 mM EDTA, pH 11.0 instead of 0.06 M sodium piiospliate buffer, 
pH 8.0 did not show any change in the slope of standard curve using Fog's 
method (1958). 
Effect of sodium azide on the determination of bilirubin 
concentration by Fog's method 
Sodium azide, a bacterio-static agent, used as preservative in many 
biological samples, was found to be highly interfering substance in the 
determination of bilirubin by Fog's method (1958). This interference was 
studied by taking a fixed concentration of bilirubin (127.0, 90.3 or 56.0 /xM) 
and increasing the amount of azide upto 0.50 mg/ml in these samples. A 
pronounced interference was noted at high azide concentrations. At an azide 
concentration of 0.50 mg/ml, there was about 96% decrease in estimated 
bilirubin at all the three bilirubin concentrations used in this study (Fig. 4). 
Therefore, use of sodium aade was avoided throughout these exp)eriments. 
Effect of haemoglobin on the determination of bilirubin 
concentration by Fog's method 
Fog's method (1958) used in this study for determination of bilirubin 
concentration was also found to be affected by the presence of haemoglobin. 
In presence of haemoglobin, absorbance of bilimbin solution after Fog's 
reaction, decreased continuously with time while absorbance of reagent II 
blank remained constant with time (Fig. 5). However, at varying concentrations 
of haemoglobin, its value varied. Therefore, use of haemolytic blood samples 
was avoided in these studies. 
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Interaction of bilirubin with red blood cells 
For studying red cell binding of bilirubin, red blood cells [BBC) with a 
haematocrit value of 50% were used which were prepared as follows : 
(i) Preparation of 50% haematocrit value of red blood cells : 
Citrated/heparinized blood, collected from slaughter houseA)lood bank, 
was centrifuged in Remi-R 8C centrifuge at 2000 rpm for 20 minutes 
and the supernatant containing serum was discarded. The white buffy 
coat above the upper surface of packed RBCs was also removed through 
gentle decantation. Red blood cells were washed three times with 0.07 
M sodium phosphate buffer containing 0.08 M NaCl, pH 7.4. The final 
packed red blood cells were collected and resuspendcd in the same 
buffer at a ratio of 1 : 1 to obtain 50% haematocrit value. The 
preparation was kept in refrigerator for further use. 
(ii) [Reparation of bilirubin solution : Fresh bilirubin solution was 
prepared by dissolving few crystals in the desired volume of 38 mM 
sodium carbonate solution containing 5 mM EDTA, pH 11.0. Bilirubin 
solution was protected from light and experiments with bilimbin were 
performed in yellow light. The concentration of bilirubin was determined 
by Fog's method (1958) as described earlier. Bilirubin solution was used 
within one hour. 
(Hi) Pr€>cedure : Binding of biliaibin to red blood cells was studied at pH 
8.0, ionic strength 0.414 and at 37°C according to the method of Bratlid 
(1972a). To 1.0 ml of albumin solution in 0.07 M sodium phosphate 
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buffer containing 0.08 M NaCi, pH 7.4, 1.0 ml of bilirubin solution was 
added and the volume was made to 5 ml with 0.07 M sodium phosphate 
buffer containing 0.08 M NaCl, pH 7.4. Then 1.0 ml of red blood cell 
suspension of 50% haematocrit value was added to it and the tubes 
were incubated for 30 minutes at 37°C after gentle shaking. After 
incubation, they were centrifuged at 2000 rpm for 20 minutes and the 
supernatant was removed by gentle decantation. The red blood cells 
were washed thrice with 0.07 M sodium phosphate buffer containing 
0.08 M NaCl, pH 7.4 such that the last supernatant was devoid of 
yellow colour. The supernatant was carefully removed and then 2.5 ml 
of 2.5% albumin solution was added. The erythrocyte-bound bilirubin 
was eluted by incubation for 30 minutes at 37°C after shaking the tubes 
gentiy. The tubes were centrifuged at 2000 rpm for 20 minutes and the 
supernatant was carefully removed by suction and then subjected to 
Fog's metiiod for bilirubin determination in the eluate. 
In some experiments, the bilirubin concentration was varied I (!) 
from 6.5 to 38.8 /xM (ii) from 13.8 to 78.3 /xM and (iii) from 20.0 to 
116.7 ^lM ] and albumin concenb^tion kept constant [ (i) 13.2 iM (ii) 
26.3 /zM and (iii) 39.5 fiM ] to obtain different bilirubin/albumin molar 
ratios. In other experiments, albumin concentration was varied [ (i) from 
14 to 84 /xM (ii) from 28 to 165 fiM and (iii) from 42 to 250 fiM ] and 
bilirubin concentration kept constant [ (i) 41.8 /xM (ii) 83.7 /xM and 
(iii) 125.5 /LxM ] to obtain different bilirubin/albumin molar ratios. In an 
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experiment, both the bilirubin and cdbumin concentrations were varied 
to obtain a constant bilirubin/albumin molar ratio. Experiments without 
albumin were also conducted. In these experiments, instead of 1.0 ml of 
albumin solution, 1.0 ml of 0.07 M sodium phosphate buffer containing 
0.08 M NaCl, pH 7.4 was taken to keep the final volume of the 
incubation mixture as 6.0 ml. 
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RESULTS AND DISCUSSION 
Isolation of plasma albumin 
Plasma albumins of human, sheep, goat and buffalo were isolated as 
described in the experimental section. About 2 gm protein was obtained from 
100 ml of the plasma. The preparation showed a fair degree of homogeneity 
as evidenced by the electrophoretic pattern in which the isolated plasma 
albumins of human, goat, buffalo and sheep gave a single band (Fig. 6). 
Binding of bilirubin to erythrocytes 
Binding of bilirubin to erythrocytes of different mammalian species was 
studied under different conditions as described in the experimental section. 
The results obtained are described below. 
(a) At different biiirubin/albumin molar ratios (keeping ttie 
bilirubin concentration constant while varying the 
albumin concentration) 
At different bilinabin/albumin molar ratios in the range of 0.5 to 3.0. 
obtained by taking fixed amount of bilirubin (41.8 /xM) and increasing 
amounts of albumin, the binding of bilirubin to erythrocytes increased 
continuously with the increase in biiirubin/albumin molar ratio as shown 
in Fig. 7. Similar pattern of binding was observed with all the four 
mammalian species studied. At two other fixed bilirubin concentrations 
(83.7 fiM and 125.5 /LtM), the binding patterns were qualitatively similar 
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Figure 6. Polyacrylamide gel electrophoresis of different plasma albumins. 
(A) Goat, (B) Buffalo, (C) Human and, (D) Sheep plasma 
albumins. 
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Figure 7. Binding of bilirubin to the erythrocytes of goat (•-•), buffalo 
(0-0), human ((M)) and sheep (0-0) at different bilirubin/albumin 
molar ratios. Bilirubin concentration was kept constant at 41.8 fiM 
and the albumin concentration varied. 
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Figure 8. Binding of bilirubin to the erythrocytes of goat {•-•), buffalo 
(0-0), human ((1-3) and sheep (0-0) at different bilirubin/albumin 
molar ratios. Bilirubin concentration was kept constant at 83.7 /xM 
and the albumin concentration varied. 
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Figure 9. Binding of bilirubin to the erythrocytes of goat (•-•), buffalo 
(0-0), human ((Ml) and sheep (0-0) at different bilirubin/albumin 
molar ratios. Bilirubin concentration was kept constant at 125.5 
fiM and the albumin concentration varied. 
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to the one obtained with 41.8 /xM bilirubin concentration. At any molar 
ratio, amount of erythrocyte-bound bilirubin increased on increasing 
bilirubin concentration (see Figs. 7 -9 ) . 
Bilirubin binding patterns as obtained with human erythrocytes 
were fairly comparable with that of eariier reports obtained with human 
system (Bratlid, 1972a; Kaufmann et al., 1967; Hayer et al, 1989). 
However, the amount of erythrocyte-bound bilirubin, in case of human 
system was smaller than that reported earlier (Bratlid, 1972a). This may 
be due to the effect of pH on this interaction as we have studied this 
binding at pH 8.0 while in an eariier study, pH was kept at 7.4 (Bratlid, 
1972 a). Several earlier reports suggest a decrease in bilirubin binding 
by erythrocytes on increasing pH (Bratiid, 1972b; Sato & Kashiwamata, 
1983). A comparison of bilirubin binding to erythrocytes obtained from 
different species suggests significant variation in bilirubin binding at all 
molar ratios. At a given molar ratio, goat er3/throcytes bind maximum 
amount of bilirubin while sheep erythrocytes bind the lowest amount 
(see Figs. 7-9) . The amount of bilirubin bound by buffalo and human 
erythrocytes was in between the values obtained with goat and sheep 
erythrocytes. Increase in erythrocyte-bound bilirubin on increasing 
bilirubin/albumin molar ratio was smaller upto a molar ratio of 1:1. On 
the other hand, at any molar ratio higher than 1:1, the increase in 
bound bilirubin was more significant. Precentage increase in bound 
bilirubin was similar in all cases on increasing the molar ratio either from 
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1.0 to 1.5 or from 1.5 to 2.0. This increase became smaller on moving 
from molar ratio 2.0 to 2.5. The value (% increase in erythrocyte-bound 
bilirubin) decreased further on increasing the molar ratio from 2.5 to 3.0. 
This is because at higher molar ratios, binding approached saturation. 
Further, at bilirubin/albumin molar ratio 2.0, the amount of erythrocyte-
bound bilirubin was found four fold with respect to the one at molar 
ratio 1.0 when bilirubin concentration was 125.5 JJM. This was in contrast 
with the report of Bratiid (1972a) who demonstrated an about eight fold 
increase in erythrocyte-bound bilirubin on increasing the molar ratio 
from 1.0 to 2.0 when bilirubin concentration was 160 fuM. It should be 
noted that at bilirubin/albumin molar ratio 2.0, both primary and 
secondary binding sites on albumin are filled and bound bilirubin at 
these sites is always in equilibrium with free bilirubin which is available 
for binding to red blood cells. Binding of bilirubin to red cells is different 
from that of albumin. Bilirubin acid especially bilirubin acid monoanion 
is considered to bind to red blood cells (Wennberg, 1988) whereas 
bilirubin dianion is bound to albumin (Brodersen, 1979). Further, 
albumin may also bind bilirubin acid monoanion as it can elute the 
erythrocyte-bound bilirubin. Thus, cellular binding of bilirubin is affected 
by pH (Bratiid, 1972 b) being higher at low pH values. As our 
experiments were performed at pH 8.0, small increase in erythrocyte-
bound bilirubin at pH 8.0 compared to large increase reported in an 
earlier study at pH 7.4 can be ascribed to pH effects. pH can affect both 
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Figure 10. Binding of bilimbin to tiie erythrocytes of goat (•-§), buffalo 
(Q-0), human (O-d) and sheep (0-0) at different bilirubin/albumin 
molar ratios. Albumin concentration was kept constant at 39.5 /xM 
and the bilirubin concentration varied. 
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the state of bilirubin as well as the physicochemical conditions of bilirubin 
binding substances on the plasma membrane of red cells as suggested 
eariier (Sato & Kashiwamata, 1983). 
(b) At different bilirubin/albumin molar ratios (Iceeping the 
albumin concentration constant while varying the 
bilirubin concentration) 
The binding patterns of bilirubin to the erythrocytes of human, 
goat, buffalo and sheep at different bilirubin/albumin molar ratios, 
obtained by keeping albumin concentration constant while varying the 
bilirubin concentration (Fig. 10) were similar to those obtained at different 
bilirubin/albumin molar ratios when bilirubin concentration was kept 
constant and albumin concentration varied. Increase in molar ratio 
caused increase in erythrocyte-bound bilirubin which was less significant 
upto a molar ratio 1:1 but became more pronounced above molar ratio 
1:1. These results stron^y suggest that binding of bilirubin to erythrocytes 
of all mammalian species studied depends on the concenti-ation of 
bilirubin and the bilirubin/albumin molar ratio. 
(c) At constant bilirubin/albumin molar ratio while varying 
both the bilirubin and albumin concentrations 
At a given constant bilirubin/albumin molar ratio, the binding of 
bilirubin to en/throq/tes increased linearly with increase in bilirubin 
concentration as shown in Figs. 11-14. This finding was consistent witii 
the earlier finding on human erythrocytes (Kaufinann et al., 1967). 
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Figure 11. Binding of biliaibin to erythrocytes of goat {%-%) buffalo (0-C), 
human (0-Q) and sheep (0-0) at constant bilirubin/albumin molar 
ratio. Both bilirubin and albumin concentrations were varied to 
obtain a constant bilirubin/albumin molar n 
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Figure 12. Binding of biJimbin to erythrocytes of goat (•-#) buffaJo (^©), 
human (d-G) and sheep (0-0) at constant bilirubin/albumin molar 
ratio. Both bilirubin and albumin concentrations were varied to 
obtain a constant bilirubin/albumin molar ratio of 2.0. 
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Figure 13. Binding of Mirubin to erythrocytes of goat (t-#) buffalo (0-0), 
human (0-3) and sheep (0-0) at constant bilirubirValbumin molar 
ratio. Both bilirubin and albumin concentrations were varied to 
obtain a constant bilirubin/albumin molar ratio of 2.5. 
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Figure 14. Binding of bilimbin to erythrocytes of goat {•-•) buffalo (Q-0), 
human (9-0) and sheep (0-0) at constant bilinjbin/albumin molar 
ratio. Both bilirubin and albumin concentrations were varied to 
obtain a constant bilirubin/albumin molar ratio of 3.0. 
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Figure 15. Plots of the slope (taken from Figures 11 -14) versus bilirubin/ 
albumin molar ratio. Various mammalian species were: 
goat (•-•), buffalo (©-0), human (0-0) and sheep (0-0). 
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However, the value of slope of the linear plots at any given bilimbin/ 
albumin molar ratio was found to be different for different erythrocytes. 
At any constant bilirubin/albumin molar ratio, the value was highest in 
case of goat erythrocytes followed by buffalo and human and lowest in 
case of sheep erythrocytes (see Figs. 11 - 14). Further, with all the 
species, highest binding was observed at highest molar ratio i.e. 3.0. 
Thus, the binding was highest in case of goat erythrocytes and lowest 
in case of sheep erythrocytes. 
Values of the slope obtained from these plots were plotted against 
bilirubin/albumin molar ratio and the results are shown in the Fig. 15. 
In all cases, initially there was a rapid increase in the value of the slope 
and then it became somewhat constant at higher molar ratios, i.e. 2.5 
and 3.0. In other words, increase in erythrocyte-bound bilirubin per unit 
increase in bilirubin concentration was found to be dependent upon 
molar ratio upto a ratio of 2.5 and then became independent above 
molar ratio 2.5 as the value was nearly constant at molar ratio 2.5 and 
3.0. This suggests the saturation of bilirubin binding sites on the 
erythrocyte membranes at higher molar ratios. From the Fig. 15, it is 
clear that saturation of bilirubin binding sites is different in different 
erythrocytes. For example, sheep erythrocytes can be saturated at lower 
bilirubin concentration as compared to other mammalian erythrocytes, 
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Figure 16. Histogram representing the percentage fractional binding of 
bilirubin to erythrocytes of various mammalian species i.e. goat 
(ED); buffalo (^); human (D) and sheep (•) at different bilirubin 
albumin molar ratios. The bilirubin/albumin molar ratios were from 
(a) 1.0 - 1.5, (b) 1.5 - 2.0, (c) 2.0 - 2.5 and (b) 2.5 - 3.0. 
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Fractional binding of bilirubin to erythrocytes 
Percentage difference in fractional binding of bilirubin to 
erythrocytes was calculated using the following equation: 
{E-B)2-(E-B), 
% difference in fractional bilirubin binding = x 100 
X 
where (E-Bjg and {E-B)j are the erythrocyte-bound bilirubin at 
higher and lower bilirubin/albumin molar ratios respectively and X is the 
concentration of bilirubin in the incubate ran^ng from 52.5-125.5 /xM. 
The values, thus obtained, were plotted against the range of bilirubin/ 
albumin molar ratios and are shown in Fig. 16. As can be seen from the 
figure, the percentage difference in fractional bilirubin binding to 
erythrocytes was found highest between bilirubin/albumin molar ratios 
of 1.5 and 2.0. In other words, greater amount of bilirubin ti-ansfers from 
plasma to cells and the transfer seems to be more pronounced at molar 
ratios of 1.5 to 2.0. At other molar ratios, percentage difference in 
fractional bilirubin binding was nearly equal to each other. A comparison 
of percentage difference in fractional bilirubin binding at molar ratios of 
1.5 to 2.0 shows that goat erythrocytes have highest percentage 
difference, reaching to a value of 16.6 ± 2.4, followed by buffalo (13.4 
± 1.9) and human erythrocytes (12.3 ± 3.0) whereas sheep erythrocytes 
have lowest percentage difference, reaching to a value of 11.4 ± 0.7. 
These data suggest that number of bilirubin binding sites in goat 
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erythrocytes is maximum followed by buffalo and human erythrocytes 
and minimum in sheep erythrocytes. 
— Relative percentage difference in bound bilirubin by the 
erythrocytes of sheep, buffalo and goat with respect to 
human erythrocytes 
The relative percentage difference in the bilirubin bound to 
erythrocytes of sheep, buffalo and goat with respect to bilirubin bound 
to human erythrocytes was calculated using the following equation: 
(E-B)^ -(E-B)„ 
Relative % difference in bound bilirubin = x 100 
(E-B)H 
where (E-B)^  is the concentration of bilirubin bound to goat, sheep or 
buffalo erythrocytes, (E-B)^  is the concentration of bilirubin bound to human 
erythrocytes. The values obtained at different bilirubin/albumin molar ratios in 
several experiments are given in Table II. At all molar ratios above 1.0. the 
value of relative percentage difference in erythrocyte-bound bilirubin with 
respect to bilirubin bound to human erythrocytes was found to be more or less 
similar. A comparison of the data shows that goat and buffalo erythrocytes 
bind bilirubin 31.8% and 11.4% respectively more as compared to human 
erythrocytes. On the other hand, sheep erythrocytes bind 8.7% less bilirubin 
as compared to human erythrocytes. Thus, binding of bilirubin was maximum 
with goat erythrocytes and minimum with sheep erythrocytes. 
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TABLE - II 
Relative percentagedifference in bilirubin binding by 
erythrocytes of different species witli respect to liuman erythrocytes 
in presence of respective plasma albumins 
Bilirubin/albumin Relative % difference in bound bilimbin by 
molcir ratio Slieep Buffalo Goat 
erythrocytes erythrocytes erythrocytes 
(%) (%) (%) 
1.5 -10.6±3.0 12.5±2.7 30.1 ±3.6 
2.0 - 8.7±2.1 11.0±2.1 32.7±2.5 
2.5 - 8.5±1.4 12.2±2.9 30.0±2.3 
3.0 - 7.4±1.2 9.8±1.3 34.5±2.2 
Mean - 8.7±1.9 11.4±2.3 31.8±2.7 
* Each value represents a mean of 13 observations. 
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Effect of plasma albumin on the binding of bilirubin to 
erythrocytes 
Although it is rep)orted that charcoal-treated serum albumins from 
different species i.e. human, bovine, rabbit and chicken have different 
affinities for bilirubin (Blauer ^/a/., 1967),however, we did not find any 
difference in the affinities of human, goat, buffalo and sheep plasma 
albumins for bilirubin. This is based on the finding that elution of 
erythrocyte-bound bilirubin with human, buffalo, goat and sheep plasma 
albumins yielded the same amount of bilirubin from human erythrocytes 
(see Table III). Further, in all the mammalian species studied, the binding 
of bilirubin to erythrocytes was found to be more or less completely 
protected in the presence of their respective albumins at a bilirubin/ 
albumin molar ratio of 0.5 as shown in Fig. 17 as well as in Table IV 
in which the ratio of erythrocyte-bound bilirubin in the presence of 
albumin (v) to erythrocyte-bound bilirubin in the absence of albumin 
(v^ ) was plotted against bilirubirValbumin molar ratio (M.R.). Due to the 
similar protection of binding of bilirubin to erythrocytes at bilirubin/ 
albumin molar ratio of 0.5 in all the mammalian species studied, we can 
reasonably claim that the difference in bilirubin bound to erythrocytes 
might be due to tiie difference in the affinities of receptors or due to 
difference in the number of receptors or due to difference in both \he 
affinities and number of receptors present on these erythrocytes. The 
binding seems to be dependent upon the amount of available free 
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TABLE III 
Comparison of elution behaviour of bilirubin bound to human 
erythrocytes by different concentration of different plasma albumins, 
namely, human, goat, buffalo and sheep plasma 
Concentration of 
plasma albumin 
used for elution 
(mg/ml) 
1.0 
5.0 
10.0 
15.0 
20.0 
25.0 
30.0 
Concentration of t 
HPA ifiM) 
24 
57.6 
75.2 
80.0 
88.0 
94.4 
96.0 
;rythrocyte-bound 
bilirubin eluted by 
BuPA (AIM) 
20.8 
52.8 
76.8 
81.6 
91.2 
86.0 
96.0 
GPA ipM) 
25.6 
60.8 
76.8 
80.0 
89.6 
94.4 
94.4 
SPA ipM) 
27.2 
60.8 
75.2 
78.4 
91.2 
94.4 
94.4 
HPA - Human plasma albumin BuPA - Buffalo plasma albumin 
GPA - Goat plasma albumin SPA - Sheep plasma albumin 
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Figure 17. Plots of the ratio of bilirubin bound to human erythrocytes in 
presence as weU as in absence of albumin against the bilirubin/ 
albumin molar ratio. 
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TABLE IV 
Effect of plasma albumin on the erythrocyte-bound bilirubin 
System m c M.R. 
(erythrocytes/albumin) 
Human 
Buffalo 
Goat 
Sheep 
0.22 
0.23 
0.28 
0.21 
-0.12 
-0.12 
-0.16 
-0.11 
0.53 
0.53 
0.55 
0.53 
Values of slope (m) and intercept (c) were taken from the following 
equation 
v/v^ = m X Bilirubin/albumin molar ratio (M.R.) + C 
where v is the erythrocyte-bound bilirubin in presence of albumin and 
v^  is the erythrocyte-bound bilirubin in absence of albumin. 
M.R.* intercept on X- axis. 
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unconjugated bilinjbin. Albumin does not compete with the binding of 
bilimbin to erythrocytes but lowers the amount of free unconjugated 
bilirubin which is available to erythrocytes. 
(d) Binding of bilirubin to erythrocytes in the absence of 
albumin 
Binding of bilirubin to erythrocytes of human, goat buffalo and 
sheep was studied in the absence of albumin by incubating the cells with 
increasing concentrations of bilirubin. The results of the erythrocyte-
bound bilirubin and the bilirubin in the incubate are shown in Fig. 18. 
In all the cases, curves showed a Michaelian saturation. These are similar 
to the one obtained earlier using human erythrocytes (Hayer et al, 
1989). From the Fig. 18, it can be seen that human, goat, buffalo and 
sheep erythrocytes have different saturation capacities. For the 
determination of dissociation constants of the bilirubin-receptor complex 
and saturation, the data from Fig. 18 were ti'ansformed into double 
reciprocal plots and the values of the slope and intercept were used for 
the calculation of the dissociation constant of the bilirubin-receptor 
complex and saturation. For simplicity, the double reciprocal plot 
obtained with human erythrocytes is shown in Rg. 19. The values oi \he 
dissociation constant of the bilirubin-receptor complex and saturation are 
listed in Table V. In the case of human erythrocytes, saturation 
corresponded to a binding of 76.9 /xmoles of bilirubin per 1000 ml 
erythrocytes and the dissociation constant of bilirubin-receptor complex 
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Figure 18. Binding of bilimbin by the erythrocytes of goat (A-A), buffalo 
(A-A), human (0-0) and sheep {#-•) in the absence of plasma 
albumin. 
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Figure 19. Double reciprocal plot between inverse of erythrocyte-bound 
bilirubin concentration and inverse of bilirubin concentration in 
the incubate for human erythrocytes. 
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TABLE V 
Interaction parameters of bilirubin with erytlirocytes of 
different species. 
Species 
Human 
Buffalo 
Goat 
Sheep 
Saturation 
11 moles of bilimbin/ 
1000 ml RBC 
76.9 
83.3 
125.9 
62.5 
Dissociation 
constant 
Ou.mol/1) 
150.0 
155.8 
265.7 
115.6 
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was found to be 150x10^ moles per litre. This value of the dissociation 
constant was 0.9 times lesser than the one reported earlier (Hayer et al., 
1989). A comparison of dissociation constant of the bilirubin-receptor 
complex (150x10^ moles/litre) with that of the bilirubin-HSA complex 
(1.5xlO« moles/litre) for primary binding site (Brodcrsen, 1979) suggests 
that the binding of unconjugated bilirubin to erythrocytes, even for high 
bilirubinemia (150 moles/litre) is extremely weak. From the Table V, it 
can be seen that goat erythrocytes have the highest dissociation constant 
whereas sheep erythrocytes have the lowest. Buffalo erythrocytes bind 
bilimbin with a dissociation constant similar to human erythrocytes. 
Similarly saturable binding on the erythrocyte membranes was maximum 
with goat erythrocytes whereas sheep erythrocytes bound the lowest 
amount of bilirubin. Thus, it appears that the number of saturable 
bilirubin binding sites on goat erythrocytes is highest of all the species 
studied whereas the number of binding sites on sheep erythrocytes is 
the lowest. Human and buffalo erythrocytes have the same number of 
binding sites and are in between goat and sheep erythrocytes. In contrast, 
the affinity of these sites was highest in sheep erythrocytes and lowest 
in goat erythrocytes. Human and buffalo erythrocytes have similar 
affinities which are in between the two. The finding of the differences in 
the binding of bilirubin to erythrocytes in the absence of albumin also 
explained the previous finding that the binding differences of bilirubin in 
goat, sheep, buffalo and human erythrocytes in presence of albumin 
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were due to the differences in the number of saturable binding sites as 
well as the bilirubin binding affinities of erythrocytes of these species. 
Since the membrane make-up of proteins (Lenard, 1970) and lipids 
(Barenholz & Thompson, 1980) and other properties such as thermal 
behaviour (Calhoun & Shipley, 1979), function of membrane proteins 
(Kramer et al., 1972), stability to osmotic shock, permeability to 
molecules for which no specific ti'ansport ^ stem exists (Deuticke, 1977) 
is different in these erythrocytes, this might account for the differences 
in the affinity as well as in the number of saturable binding sites on these 
erythrocytes. The results on the binding studies of bilirubin to goat, 
human, buffalo and sheep erythrocytes suggest that bilirubin receptors 
on the membrane of different erythrocytes differ not only in the number, 
but also in their receptor affinities. These differences in affinity may be 
due to the different stiuctures of these receptors or might be due to other 
factors. 
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